|
de la Morena-Barrio ME, Martínez-Martínez I, de Cos C, Wypasek E, Roldán V, Undas A, van Scherpenzeel M, Lefeber DJ, Toderici M, Sevivas T, España F, Jaeken J, Corral J, Vicente V. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect. J Thromb Haemost. 2016 Aug;14(8):1549-60. doi: 10.1111/jth.13372. Epub 2016 Jun 29. PubMed PMID: 27214821.
AÑO: 2016; IF: 5.287
|
27214821
|
García-Fernández A, Roldán V, Rivera-Caravaca JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? Sci Rep. 2017 Jan 30;7:41565. doi: 10.1038/srep41565. PubMed PMID: 28134282; PubMed Central PMCID: PMC5278507.
AÑO: 2017; IF: 4.122
|
|
B Arroyo A, Salloum-Asfar S, Pérez-Sánchez C, Teruel-Montoya R, Navarro S, García-Barberá N, Luengo-Gil G, Roldán V, Hansen JB, López-Pedrera C, Vicente V, González-Conejero R, Martínez C. Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens. Sci Rep. 2017 Feb 27;7:43500. doi: 10.1038/srep43500. PubMed PMID: 28240250; PubMed Central PMCID: PMC5327489.
AÑO: 2017; IF: 4.122
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost. 2017 Jun 27;117(7):1448-1454. doi: 10.1160/TH16-12-0961. Epub 2017 Mar 23. PubMed PMID: 28331926.
AÑO: 2017; IF: 6.681
|
|
Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Raña-Míguez P, Anguita M, Muñiz J, Cequier Á, Bertomeu-Martínez V, Valdés M, Vicente V, Lip GYH, Roldán V. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. Am J Cardiol. 2017 Dec 15;120(12):2176-2181. doi: 10.1016/j.amjcard.2017.09.003. Epub 2017 Sep 19. PubMed PMID: 29111209.
AÑO: 2017; IF: 3.171
|